<DOC>
	<DOCNO>NCT03034174</DOCNO>
	<brief_summary>The objective study describe pharmacokinetics tigecycline critically ill patient receive continuous venovenous haemodialysis ( CVVHD ) evaluate frequency pharmacokinetic/pharmacodynamic target attainment high dosing strategy ( 200 mg load dose 100 mg/12h ) .</brief_summary>
	<brief_title>Pharmacokinetics High-dose Tigecycline Critically Ill Patients</brief_title>
	<detailed_description>This prospective observational study perform critically ill patient . Inclusion criterion : severe sepsis admission require broad-spectrum antibiotic . Both medical surgical patient include . Any type infection include ( pulmunary , abdominal , urinary tract , etc . ) Antibiotcs regimen include : tygecycline ( 200 mg every 12 hour intravenously ) , meropenem ( 2 gram every 8 hour intravenously ) . Blood sampels ( 3 mL ) collect 2 , 4 , 8 12 hour dose tigecycline 3 consecuetive day . The standard arterial canula use obtain sample . In case CVVHD start continue least 3 day ' period . 30 minute collection sample centrifuge 10 minute 3,000 rpm . Subsequenly , supernatant collect frozen . Serum tygecycline concentration measure high performance liquid chromatography . Each patient 's hemodynamics parameter record use tranpulmonary thermodilution technique ( PICCO ) . Other therapy i.e . : ventilatory support , sedation , antifungal agent give requierd .</detailed_description>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<mesh_term>Tigecycline</mesh_term>
	<mesh_term>Minocycline</mesh_term>
	<criteria>Patients require ICU treatment due severe sepsis age 1880 year CVVHD treatment eligible consent obtain patient his/her attendant allergy tigecycline meropenem contraindication CVVHD lack consent participate study age patient 18 80 year</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>tigecycline</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>